Private Payors Curtailing Excessive Diagnostic Imaging – Health Affairs Study
This article was originally published in The Gray Sheet
Private insurers are returning to cost-containment strategies, including limiting superfluous diagnostic tests, in the face of rising healthcare costs coupled with an economic slowdown, an Aug. 11 Health Affairs web exclusive maintains
You may also be interested in...
The Medicare Payment Advisory Commission plans to continue exploring whether Medicare should do more to emulate private insurers' strategies for controlling the growth of imaging services during the next year
Celltrion has accelerated the development of its antiviral treatment for COVID-19 and aims to launch a rapid self-testing kit that could provide results within 15-20 minutes. The Korean firm also plans to develop a ‘super antibody’ to prepare for potential future pandemic situations.
Paracetamol, acetylcysteine and loperamide among list of OTC drugs deemed "essential" by Spain in the fight against coronavirus.